Novo Nordisk
Contact Us

Change the course of diabetes for good.

Click here
to accept or decline your invitation.

Diabetes mellitus has reached epidemic proportions worldwide. The World Health Organization has commented there is “an apparent epidemic of diabetes which is strongly related to lifestyle and economic change.” Over the next decade the projected number will exceed 200 million, possibly reaching 250 million persons. While the pace of new scientific discoveries has increased the ability to apply these discoveries effectively to individuals and to populations has lagged.

Summit Meeting Co-Chairmen

Alan J. Garber MD, PhD

Professor, Departments of Medicine Biochemistry, Molecular Biology & Molecular & Cellular
Biology, Baylor College of Medicine, Division of Endocrinology
Houston, Texas

Jay S. Skyler, MD
Director, Division of Endocrinology, Diabetes, and Metabolism
University of Miami
Chairman, NIDDK Type 1 Diabetes TrialNet
Miami, Florida

If you are an employee of Novo Nordisk and wish to register for the Diabetes Summit, please click here.